What Causes Severe Fatigue in ITP Patients? Key Factors
At a Glance
Severe fatigue in ITP is not explained by platelet counts alone. Immune activity, treatment side effects, emotional strain, anemia or low iron, sleep disorders, loss of fitness, and other illnesses can contribute, so persistent or worsening fatigue needs medical evaluation.
Fatigue is one of the most common and disruptive symptoms of Immune Thrombocytopenia (ITP), yet it is frequently misunderstood. If you are exhausted all the time even when your platelet counts are perfectly normal, your experience is entirely valid. Research shows that more than half of adults with ITP experience significant fatigue, and for those with chronic ITP, that number is even higher [1]. Importantly, clinical studies have found that platelet counts alone are a poor predictor of your energy levels [2][3]. Fatigue in ITP is a multifactorial reality that may be influenced by immune system changes, treatment side effects, the mental burden of chronic illness, and other medical factors [4][5].
When to Seek Urgent Help
Never assume that severe or rapidly worsening fatigue is “just part of having ITP.” Fatigue can be a warning sign of a more serious medical issue. Seek immediate medical evaluation if your fatigue is accompanied by:
- Uncontrolled bleeding, black or bloody stools, or vomiting blood
- Fainting, severe dizziness, or confusion
- Severe shortness of breath or chest pain
- A new, severe headache or sudden weakness
- Fever or chills, which is a medical emergency if you have had a splenectomy (removal of your spleen) or are taking immune-suppressing medications [6].
The Biological Link: Immune System Changes
ITP is an autoimmune condition, meaning your immune system mistakenly targets your own platelets. When your immune system is active, it creates an inflammatory environment in your body.
Researchers are studying how this immune activity might contribute to exhaustion. The immune system releases pro-inflammatory cytokines, which are signaling proteins that control inflammation. It is theorized that these cytokines send signals to the nervous system that mimic “sickness behavior”—the profound exhaustion you feel when fighting off a severe flu [4]. For instance, research has shown an association between elevated levels of a specific cytokine called Interleukin-12 (IL-12) and worse fatigue in ITP patients [7].
However, IL-12 is a research finding, not a routine diagnostic test, and these cytokine levels are an association rather than a proven direct cause of fatigue for every patient. Your normal platelet count neither proves nor disproves that underlying immune activity is contributing to your exhaustion.
The Toll of ITP Treatments
Sometimes the therapies used to manage ITP contribute to exhaustion more than the disease itself. Any evaluation of fatigue must include a thorough review of your medications.
- Corticosteroids: Medications like prednisone or dexamethasone are notorious for causing side effects that drain energy. They can lead to insomnia, mood changes, weight gain, and muscle weakness [5]. Prolonged use creates a substantial physical burden [8]. Never stop taking steroids abruptly, as this can cause dangerous withdrawal symptoms and severe weakness; any dose reduction must be carefully planned with your doctor.
- Immunosuppressants: Medications like rituximab suppress your immune system and carry risks of infusion reactions and prolonged depletion of immune cells, which can affect how you feel day-to-day [9].
- Splenectomy: Removing the spleen carries lifelong considerations. While it can manage ITP, patients without a spleen require specific vaccinations and are at a higher risk for severe infections and blood clots [10][6]. A fever post-splenectomy requires immediate medical attention, and persistent fatigue should prompt an evaluation for complications rather than being accepted as normal.
- TPO-Receptor Agonists (TPO-RAs): Medications like eltrombopag or romiplostim stimulate the body to produce more platelets. While some studies show they can improve overall health-related quality of life (how your disease impacts your daily functioning), they are not a specific “cure” for fatigue and come with their own risks, such as liver or clotting issues [11]. Treatment changes should be highly individualized and made only in consultation with your hematology team.
The Mental and Emotional Weight
Living with a chronic, unpredictable illness carries a heavy mental burden. The constant uncertainty about bleeding risks, frequent blood draws, and navigating a complex disease takes a massive toll on your energy.
Studies show that emotional and social well-being are significantly associated with fatigue levels in chronic ITP [12]. Rates of diagnosed clinical anxiety and depression are notably higher in ITP patients compared to the general population [13]. The mental energy required to navigate illness-related uncertainty can easily manifest as severe physical exhaustion.
Other Physical Factors
When platelet counts are safe but fatigue persists, a clinician-guided review should evaluate other underlying medical factors:
- Anemia and Iron Deficiency: Anemia (a lack of healthy red blood cells) or even minor, unnoticed bleeding over time can deplete your body’s iron stores. Low ferritin (a protein that stores iron) is associated with fatigue in ITP patients [3]. However, ferritin can also be elevated just from inflammation, so a doctor must carefully interpret these labs alongside your complete blood count (CBC) to determine if iron supplementation is truly needed.
- Sleep Disorders: Poor sleep quality is heavily linked to severe fatigue in ITP. Conditions like obstructive sleep apnea, insomnia (often triggered by steroids or anxiety), and frequent awakenings prevent restorative sleep [3][14].
- Deconditioning: Severe fatigue often leads to physical deconditioning—a loss of muscle tone and stamina from reduced physical activity. This creates a vicious cycle where everyday tasks feel progressively more exhausting [12].
- Other Medical Causes: A thorough medical review should also consider thyroid disorders, kidney or liver disease, B12 or folate deficiencies, or underlying infections.
What You Can Do Now
While investigating the causes with your care team, there are practical steps you can take to manage your energy:
- Track Your Symptoms: Keep a simple fatigue diary. Note your fatigue severity, sleep hours, medication timing and dose changes, bleeding or menstrual symptoms, mood, and activity levels. This makes it much easier to identify specific patterns with your doctor.
- Pacing and Energy Conservation: Do not push through severe exhaustion. Break tasks into smaller steps, prioritize what needs to be done, and plan rest periods throughout the day.
- Gradual Activity: If cleared by your hematology team and your bleeding risks are low, tailored, gentle physical activity (or physical therapy) may help combat physical deconditioning without overtaxing your body.
Common questions in this guide
Can ITP cause severe fatigue even when my platelet count is normal?
What can cause extreme tiredness in someone with ITP?
Can ITP medicines make fatigue worse?
What tests can help find the cause of fatigue when I have ITP?
When is severe fatigue with ITP an emergency?
How can I manage ITP-related fatigue while the cause is being evaluated?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since my platelet count is stable but I am still exhausted, can we do a comprehensive evaluation (including CBC, iron/ferritin, thyroid, B12, and liver/kidney function) to check for other physical causes?
- 2.Could any of my current treatments, particularly corticosteroids or immunosuppressants, be contributing to my fatigue?
- 3.What symptoms should prompt me to call the clinic or seek emergency care the same day?
- 4.Would you recommend a referral for a sleep study, physical therapy, or psychological support to help me manage the daily impact of this fatigue?
- 5.What is my individualized safe platelet target, and how does it balance my bleeding risk with the side effects of my treatments?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Epidemiology, Treatment Patterns, and Cost Analysis of Immune Thrombocytopenia in Spain between 2014 and 2020: A Population-based Study.
González-López TJ, Alperovich G, Burillo E, et al.
TH open : companion journal to thrombosis and haemostasis 2024; (8(3)):e252-e265 doi:10.1055/a-2336-1062.
PMID: 38983689 - 2
[Predictors of fatigue among individuals with primary immune thrombocytopenia in China].
Li Y, Lyu ME, Hao YT, et al.
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017; (38(5)):384-389 doi:10.3760/cma.j.issn.0253-2727.2017.05.006.
PMID: 28565736 - 3
Identification of an Unmet Medical Need: Height of Depression, Hypersomnia, and Sleep Apnea Positively Correlate With the Level of Fatigue in Patients With Immune Thrombocytopenia.
Alesci RS, Hecking C, Weissmann MV
Cureus 2023; (15(10)):e47003 doi:10.7759/cureus.47003.
PMID: 37965409 - 4
Fatigue in immune thrombocytopenia.
Hill QA, Newland AC
British journal of haematology 2015; (170(2)):141-9 doi:10.1111/bjh.13385.
PMID: 25823426 - 5
Immune Thrombocytopenia (ITP): Current Limitations in Patient Management.
Terrell DR, Neunert CE, Cooper N, et al.
Medicina (Kaunas, Lithuania) 2020; (56(12)) doi:10.3390/medicina56120667.
PMID: 33266286 - 6
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature.
Castelli R, Atzori E, Delitala AP, et al.
Frontiers in cardiovascular medicine 2025; (12()):1508574 doi:10.3389/fcvm.2025.1508574.
PMID: 40013124 - 7
Plasma interleukin-12 levels as a potential biomarker of fatigue and quality of life in patients with primary immune thrombocytopenia.
Wadhera S, Jain A, Sahni A, et al.
Blood research 2025; (60(1)):63 doi:10.1007/s44313-025-00112-3.
PMID: 41339997 - 8
Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern.
Cuker A, Liebman HA
Research and practice in thrombosis and haemostasis 2021; (5(6)):e12592 doi:10.1002/rth2.12592.
PMID: 34466771 - 9
Investigational drugs for immune thrombocytopenia.
Provan D, Newland AC
Expert opinion on investigational drugs 2022; (31(7)):715-727 doi:10.1080/13543784.2022.2075340.
PMID: 35531637 - 10
A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.
Rodeghiero F
British journal of haematology 2018; (181(2)):183-195 doi:10.1111/bjh.15090.
PMID: 29479668 - 11
Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.
Britto J, Holbrook A, Sun H, et al.
Clinical and investigative medicine. Medecine clinique et experimentale 2024; (47(1)):13-22 doi:10.3138/cim-2024-2569.
PMID: 38546381 - 12
Possible Targets to Reduce Fatigue in Chronic Immune Thrombocytopenia Patients - An Explorative Study.
van Dijk WEM, Nap-van der Vlist MM, Knoop H, Schutgens REG
TH open : companion journal to thrombosis and haemostasis 2022; (6(4)):e387-e395 doi:10.1055/s-0042-1758546.
PMID: 36452201 - 13
Mental health and use of psychotropic prescription drugs in adult patients with primary immune thrombocytopenia: a nationwide population-based cohort study.
Mannering N, Hansen DL, Pottegård A, et al.
Haematologica 2024; (109(9)):2944-2954 doi:10.3324/haematol.2024.285364.
PMID: 38721747 - 14
Platelet count and sleep quality in immune thrombocytopenia: correlation with 5-hydroxytryptamine and therapeutic implications of platelet-5-HT-melatonin axis dysregulation.
Jiao Y, Fan W, Wang Y, et al.
Frontiers in neurology 2025; (16()):1645796 doi:10.3389/fneur.2025.1645796.
PMID: 41211279
This page explains possible causes of severe fatigue in people with ITP for informational purposes only and does not replace medical advice. Contact your hematology team about persistent or worsening fatigue.
Get notified when new evidence is published on Immune thrombocytopenia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.